Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Organizations Call on GSK to Join UNITAID Patent Pool

From Henry J. Kaiser Family Foundation

September 9, 2009

A letter from 15 organizations -- including the Stop Aids Campaign, Medicines Sans Frontiers, UNICEF and Christian Aid -- calls on drug company GlaxoSmithKline to join UNITAID's patent pool, "which aims to improve access to drugs for HIV/AIDS and other diseases in poor countries," the Guardian writes. Andrew Witty, the chief executive of GSK, has cut prices of drugs in developing countries and "launched a patent pool of his own, with more than 800 compounds and molecules that might be useful to researchers into neglected diseases," but he says AIDS is not neglected (Boseley, 9/6).

Back to other news for September 2009


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.
 
See Also
More on HIV Drug Patent Policies

 

Advertisement